title: Systematic prioritization of cancer combination therapies: are we really on target?
authors.forename: Margaret S
authors.initials: MS
authors.lastname: Lee
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D015195:Drug Design; D023281:Genomics; D006801:Humans; D009369:Neoplasms / Q000191:economics / Q000628:therapy*; D057285:Precision Medicine
chemical_list: D000911:Antibodies, Monoclonal